Nyxoah Q2 operating loss widens to EUR 20.59 million; revenue more than doubled to EUR 7.68 million vs Q2 FY25
Reuters2026/08/05 20:11- Nyxoah posted Q2 net sales of EUR 7.7 million, up from EUR 1.3 million a year earlier; US net sales rose 22% sequentially to EUR 5.2 million.
- Operating loss widened to EUR 20.6 million from EUR 19.9 million; loss attributable to shareholders deepened to EUR 33.0 million from EUR 20.6 million.
- Gross margin slipped to 60% from 63%, while cash, cash equivalents and financial assets climbed to EUR 97.8 million at June 30 from EUR 48.0 million at end-2025.
- US rollout accelerated with 89 new centers activated to 180 high-volume active centers; 55 new surgeons trained lifted the total to 262.
- Full-year 2026 net sales outlook was maintained at EUR 36 million to EUR 40 million; total operating expenses guidance was raised to EUR 99 million to EUR 102 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro holds gains above 1.1600 despite robust US jobs data, traders eye ECB rate decision
Port of Tauranga wins fast-track approval for Stella Passage development
The first major "exam" after the Cook era! Morgan Stanley: Apple's (AAPL.US) autumn launch event is the most important in ten years; the first foldable iPhone may spark a new wave of growth
Morgan Stanley analysts stated that Apple's upcoming "Surprise and Shine" autumn product launch event on September 9 may become the company's most important product release in nearly a decade.
Crypto prices
More
